secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOROX CO /DE/ (CLX)
CIK:        0000021076
Form:       8-K
Filed at:   2024-08-01T23:59:59+00:00
Accession:  0000021076-24-000027
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clorox Q4 net sales -6% to $1.9B; adjusted EPS +9% to $1.82; divests VMS business
--------------------------------------------------------------------------------

- Q4 GAAP diluted EPS $1.73 (+22% YoY); adjusted EPS $1.82 (+9%) vs $1.67.
- Gross margin 46.5% (+380 bps) on lower costs; organic sales -3%.
- Announces sale of Better Health VMS business to Piping Rock Health Products; no deal value disclosed.
- FY24 free cash flow $483M vs $930M; net cash from ops $695M.
- FY25 outlook: expects return to volume growth consistent with long-term goals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/21076/000002107624000027/0000021076-24-000027-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/21076/000002107624000027/clx-20240801.htm
  HTML page:      https://secwatch.observer/filing/0000021076-24-000027

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer